PlainRecalls

Acella Pharmaceuticals, LLC

16 recalls on record · Latest: May 13, 2026

Subscribe to new Acella Pharmaceuticals, LLC recalls (RSS)

Agency notice ledger

Federal filing book Acella Pharmaceuticals, LLC LIGHT-BOOK · SINGLE-AGENCY

#956 of 14,151 · 16 notices · 0.015% archive

  • BOOK 16 notices
  • RANK #956 of 14,151
  • SHARE 0.015% archive
  • AGENCY FDA Drug (16)
  • CAT drugs
  • CATS 3 categories
  • LATEST May 13, 2026
  • PHOTO Bella Pharmaceuticals…

Nearest notice-volume peer: Bella Pharmaceuticals, Inc. (0 notice gap)

Acella Pharmaceuticals, LLC accounts for about 0.015% of the 104,423-notice archive on 16 distinct filings — a mid share signal beside absolute volume. FDA · CPSC · USDA FSIS · NHTSA notice stamps for this firm. Read with this firm → · Dominant category → · Similar-volume firm →

How Acella Pharmaceuticals, LLC compares to 14,151 recalling firms

Acella Pharmaceuticals, LLC ranks 956th of 14,151 tracked firms by distinct recall-event count. Archive size reflects filing volume, not inherent product danger.

Acella Pharmaceuticals, LLC vs all firms by recall-notice count

Where this firm's archive sits among every tracked recalling manufacturer

16 956th of 14151 higher than 13,145 of 14,151 firms

Firms, banded by distinct federal recall-event inventory

Each bar is a band; taller bars hold more firms. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source FDA · CPSC · USDA FSIS · NHTSA federal recall filings · 2026-09-13

Acella Pharmaceuticals, LLC in the notice-volume neighbourhood

Distinct federal recall events among this firm and nearest nationwide peers

notices

What this shows Acella Pharmaceuticals, LLC holds about 0.015% of archive notices alongside 16 distinct filings.

Source FDA · CPSC · USDA FSIS · NHTSA filings aggregated by PlainRecalls As of September 2026
FDA Drug Moderate May 13, 2026

NAPROXEN ORAL SUSPENSION, USP, 125 mg/5mL, Rx only, 16fl oz (473 mL) bottles, Distributed by: Acella Pharmaceuticals, LLC, Alpharetta, GA 30005, Made in Canada NDC 42192-619-16

FDA Drug Moderate Oct 15, 2025

Doxycycline Hyclate Tablets, USP 100 mg*, 500-count bottle, Rx Only, Distributed by: Acella Pharmaceuticals, LLC, Alpharetta, GA 30005, NDC 42192-501-05.

FDA Drug Low May 15, 2024

Sodium Sulfacetamide 10% - Sulfur 5% Cleanser, Rx Only, 6 oz (170.3 g) Bottle, Manufactured for Acela Pharmaceuticals, LLC Alphareta, GA 30005, NDC 42192-136-06

FDA Drug Low Dec 7, 2022

Sodium Sulfacetamide 10% Sulfur 4% Cleansing Pads, Net weight 3.7g (60 cleansing pads Net weight 3.7 g each per carton,) Rx Only, Manufactured For: Acella Pharmaceuticals, LLC Alpharetta, GA 300025, NDC 42192-113-60

FDA Drug Low Nov 30, 2022

Phenytoin Sodium Injection, USP, 250 mg/5 mL, NDC 42192-614-05, packaged in 10 x 5 mL vials per carton, NDC 42192-614-30, Rx only, Manufactured for: Acella Pharmaceuticals, LLC Alpharetta, GA 30005

FDA Drug Low Nov 30, 2022

Phenytoin Sodium Injection, USP 100 mg/2 mL, NDC 42192-614-02, packaged in 10 x 2 mL vials per carton, NDC 42192-614-10, Rx only, Manufactured for: Acella Pharmaceuticals, LLC Alpharetta, GA 30005

FDA Drug Critical Jun 2, 2021

NP Thyroid 120 Thyroid Tablets, USP 2 grain (120 mg), packaged in a) 100-count bottles (NDC 42192-328-01) and b) 7-count bottles (NDC 42192-328-07) Rx Only, Manufactured For: Acella Pharmaceuticals, LLC Alpharetta, GA 30005

FDA Drug Critical Jun 2, 2021

NP Thyroid 30 Thyroid Tablets, USP 1/2 grain (30 mg), packaged in a) 100-count bottles (NDC 42192-329-01) and b) 7-count bottles (NDC 42192-329-07), Rx Only, Manufactured For: Acella Pharmaceuticals, LLC Alpharetta, GA 30005

FDA Drug Critical Jun 2, 2021

NP Thyroid 60 Thyroid Tablets, USP 1 grain (60 mg) 100-count bottles, Rx Only Manufactured For: Acella Pharmaceuticals, LLC Alpharetta, GA 30005, NDC 42192-330-01

FDA Drug Critical Jun 2, 2021

NP Thyroid 90 Thyroid Tablets, USP 1&1/2 grain (90 mg) 100-count bottles, Rx only, Manufactured For: Acella Pharmaceuticals, LLC Alpharetta, GA 30005, NDC 42192-331-01

FDA Drug Critical Jun 2, 2021

NP Thyroid 15 Thyroid Tablets, USP 1/4 grain (15 mg), packaged in a) 100-count bottles (NDC 42192-327-01) and b) 7-count bottles (NDC 42192-327-07), Rx Only, Manufactured For: Acella Pharmaceuticals, LLC Alpharetta, GA 30005

FDA Drug Critical Oct 28, 2020

NP Thyroid 15,Thyroid Tablets, USP 1/4 grain (15 mg) 100-count bottles, Rx Only, Manufactured For: Acella Pharmaceuticals, LLC Alpharetta, GA 30005, NDC 42192-327-01

FDA Drug Critical Oct 28, 2020

NP Thyroid 120, Thyroid Tablets, USP 2 grain (120 mg) 100-count bottles, Rx Only, Manufactured For: Acella Pharmaceuticals, LLC Alpharetta, GA 30005, NDC 42192-328-01

FDA Drug Critical Jun 10, 2020

NP Thyroid 60, Thyroid Tablets, USP, 1 grain (60 mg), 100-count bottles, Rx Only, Manufactured For: Acella Pharmaceuticals, LLC, Alpharetta, GA 30005, NDC 42192-330-01.

FDA Drug Critical Jun 10, 2020

NP Thyroid 30, Thyroid Tablets, USP, 1/2 grain (30 mg), 100-count bottles, Rx Only, Manufactured For: Acella Pharmaceuticals, LLC, Alpharetta, GA 30005, NDC 42192-329-01.

FDA Drug Critical Jun 10, 2020

NP Thyroid 90, Thyroid Tablets, USP, 1 & 1/2 grain (90 mg), 100-count bottles, Rx Only, Manufactured For: Acella Pharmaceuticals, LLC, Alpharetta, GA 30005, NDC 42192-331-01.

Acella Pharmaceuticals, LLC holds a measurable archive slice

Drug and device firms outside this manufacturer and state, matched by notice volume and category footprint.

Frequently Asked Questions

How many federal recall notices name Acella Pharmaceuticals, LLC?
PlainRecalls indexes 16 distinct federal recall events naming Acella Pharmaceuticals, LLC, aggregated from FDA, CPSC, USDA FSIS, and NHTSA filings (archive as of September 2026). That count is an issuance inventory, not a hazard score.
Where does Acella Pharmaceuticals, LLC sit among other recalling firms?
Acella Pharmaceuticals, LLC ranks #956 of 14,151 by distinct recall-event count among 14,151 firms in this archive (93rd percentile of firms with fewer notices). Rank tracks filing frequency, not product danger.
Which agency issues most of Acella Pharmaceuticals, LLC's notices?
FDA Drug accounts for 16 of this firm's 16 indexed notices.
What product category dominates Acella Pharmaceuticals, LLC's filing book?
Filings for Acella Pharmaceuticals, LLC span 3 product categories, led by drugs. Browse that category archive for peer firms and related notices.
Is a higher notice count more dangerous?
No. Archive size reflects how often federal agencies publish recalls naming the firm — reporting volume, coverage, and product range all move the number. Always verify the individual notice with the issuing agency before acting on a specific product.
Acella Pharmaceuticals, LLC: 16 federal recall notices aggregated from FDA, CPSC, USDA FSIS, and NHTSA filings (lead agency FDA Drug). Verify individual notices with FDA directly before acting on a specific recall.

Firm-level totals aggregate distinct federal recall events naming Acella Pharmaceuticals, LLC; individual notices remain authoritative on each linked recall page.

Methodology · Corrections · FDA · CPSC · USDA FSIS · NHTSA · Archive as of September 2026